Reference priceEUR €577.50Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Pomalyst |
|---|---|
| Manufacturer | Celgene Corporation |
| Prescription required | Yes |
Pomalyst 10mg C psulas duras,21 x 10mg(pomalidomide)
pomalidomide
Description
Pomalyst 10mg C psulas duras,21 x 10mg(pomalidomide) is a medicine catalog record in the MediPriceHub database. Active ingredient: pomalidomide. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Celgene Corporation. Therapeutic category: Medicine Library > Oncology Medicines > Myeloma (myelofibrosis) drugs. Pack information: 10 1 x 21. Origin country or market: Spain. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
POMALYST is a thalidomide analogue indicated for the treatment of adult patients: • in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy . • with AIDS-related Kaposi sarcoma (KS) after failure of highly active antiretroviral therapy (HAART) or in patients with KS who are HIV-negative. This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s) .How to Use
Use pomalidomide under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: pomalidomide. Pack size: 10 1 x 21. Pack unit: box. Manufacturer: Celgene Corporation. Origin country: Spain. Source category: Medicine Library > Oncology Medicines > Myeloma (myelofibrosis) drugs. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Indicaciones: 2 excipientes: PROPILENGLICOL. LACTOSA. Snomed CT: Origen y fecha de los datos:Esta información es solo orientativa. Consulta a un profesional sanitario antes de usar cualquier medicamento.